Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Blood

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood|August 1, 1983
High-dose cytosine arabinoside therapy for refractory leukemiaR H Herzig, S N Wolff, H M Lazarus, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood|August 1, 1983
High-dose cytosine arabinoside therapy for refractory leukemiaR H Herzig, S N Wolff, H M Lazarus, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Pageof 1